Long-term response of primary biliary cirrhosis (stage I) to therapy with ursodeoxycholic acid

Hepato-Gastroenterology

Volumn 52, Issue 63, 2005, Pages 753-756

  Tromm, Andreas ^a,d   May, B ^b   Klein, C G ^b   Klein, R ^c   Fisseler Eckhoff, A ^b   Griga, Th ^b  

^a Evangelisches Krankenhaus Hattingen gGmbH   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d Ev Krankenhaus Hattingen gGmbH   (Germany)

Author keywords

Primary biliary cirrhosis; Ursodeoxycholic acid

Indexed keywords

MITOCHONDRION ANTIBODY; URSODEOXYCHOLIC ACID;

ADULT; ARTICLE; BLOOD CHEMISTRY; CASE REPORT; CHOLESTASIS; CHRONIC DRUG ADMINISTRATION; DRUG RESPONSE; FEMALE; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FUNCTION TEST; MAINTENANCE THERAPY; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; REMISSION; RETREATMENT; SEROLOGY;

BILE DUCTS, INTRAHEPATIC; CHOLAGOGUES AND CHOLERETICS; CHOLESTASIS, INTRAHEPATIC; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER; LIVER CIRRHOSIS, BILIARY; LIVER FUNCTION TESTS; LONG-TERM CARE; MIDDLE AGED; MITOCHONDRIA, LIVER; PROGNOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; URSODEOXYCHOLIC ACID;

EID: 20644448609     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Heathcote J: Treatment of primary biliary cirrhosis. J Gastroenterol Hepatol 1996; 11:605-609.
2. Eriksson LS, Olsson R, Glauman H, Prytz H, Befrits R, Ryden BO, Einarsson K, Lindgren S, Wallerstedt S, Weden M: Ursodeoxycholic acid treatment in patients with primary biliary cirrhosis. A Swedish multicentre, double-blind, randomized controlled study. Scand J Gastroenterol 1997; 32:179-186.
3. Klein R, Pointner H, Zilly W, Glassner-Bittner B, Breuer N, Garbe W, Fintelmann V, Kalk JF, Müting D, Fischer R, Tittor W, Pausch J, Maier KP, Berg PA: Antimitochondrial antibody profiles in primary biliary cirrhosis distinguish at early stages between a benign and a progressive course: a prospective study on 200 patients followed for 10 years. Liver 1997; 17:119-128.
4. Poupon RE, Bonnand AM, Chretien Y, Poupon R: Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis. The UDCA-PBC Study Group. Hepatology 1999; 29:1668-1671.
5. Angulo P, Batts KP, Therneau TM, Jorgensen RA, Dickson ER, Lindor KD: Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis. Hepatology 1999; 29:644-647.
6. Combes B, Carithers RLJ, Maddrey WC, Lin D, McDonald MF, Wheeler DE, Eiogenbrodt EH, Munoz SJ, Rubin R, Garcia-Tsao G: A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology 1995; 22:759-766.
7. Heathcote EJ, Cauch-Dudek K, Walker V, Bailey RJ, Blendis LM, Ghent CN, Michieletti P, Minuk GY, Pappas SC, Scully LJ: The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology 1994; 19:1149-1156.
8. Poupon RE, Balkau B, Eschwege E, Poupon R: A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group. NEJM 1991; 324:1548-1554.
9. Poupon RE, Eschwege E, Poupon R: Ursodeoxycholic acid for the treatment of primary biliary cirrhosis. Interim analysis of a double-blind multicentre randomized trial. The UDCA-PBC Study Group. J Hepatol 1990; 11:16-21.
10. van Hoogstraten H, De Smet M, Renooij W, Breed JG, Engels LG, Den Ouden-Muller JW, Rijk MC, Smit AM, Zwertbroek R, Hop WC, van Berge Henegouwen GP, Schalm SW, van Buuren HR: A randomized trial in primary biliary cirrhosis comparing ursodeoxycholic acid in daily doses of either 10 mg/kg or 20 mg/kg. Dutch Multicentre PBC Study Group. Aliment Pharmacol Ther 1998; 12:965-971.
11. Leuschner M, Güldutuna S, You T, Hubner K, Bhatti S, Leuschner U: Ursodeoxycholic acid and prednisolone versus ursodeoxycholic acid and placebo in the treatment of early stages of primary biliary cirrhosis. J Hepatol 1996; 25:49-57.
12. Leuschner M, Maier KP, Schlichting J, Strahl S, Herrmann G, Dahm HH, Ackermann H, Happ J, Leuschner U: Oral budesonide and ursodeoxycholic acid for treatment of primary biliary cirrhosis: results of a prospective double-blind trial. Gastroenterology 1999; 117:918-925.
13. Gonzalez-Koch A, Brahm J, Antezana C, Smok G, Cumsille MA: The combination of ursodeoxycholic acid and methotrexate for primary biliary cirrhosis is not better than ursodeoxycholic acid alone. J Hepatol 1997; 27:143-149.
14. Kaplan MM: The use of methotrexate. colchicine, and other immunomodulatory drugs in the treatment of primary biliary cirrhosis. Semin Liver Dis 1997; 17:129-136.
15. Angulo P, Dickson ER, Therneau TM, Jorgensen RA, Smith C, DeSotel CK, Lange SM, Anderson ML, Mahoney DW, Lindor KD: Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial. J Hepatol 1999; 30:830-835.
16. Lindor KD, Therneau TM, Jorgensen RA, Malinchoc M, Dickson ER: Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis. Gastroenterology 1996; 110:1515-1518.
17. Degott C, Zafrani ES, Callard P, Balkau B, Poupon RE, Poupon R: Histopathological study of primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment on histology progression. Hepatology 1999; 29:1007-1012.
18. Poupon RE, Poupon R, Balkau B: Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group. NEJM 1994; 330:1342-1347.
19. Lindor KD, Jorgensen RA, Therneau TM, Malinchoc M, Dickson ER: Ursodeoxycholic acid delays the onset of esophageal varices in primary biliary cirrhosis. Mayo Clin Proc 1997; 72:1137-1140.
20. Klein R, Kloppel G, Fischer R, Fintelmann V, Muting D, Berg PA: The antimitochondrial antibody anti-M9. A marker for the diagnosis of early primary biliary cirrhosis. J Hepatol 1988; 6:299-306.
21. Bateson MC, Gedling P: Ursodeoxycholic acid therapy for primary biliary cirrhosis. A 10-year British single-centre population-based audit of efficacy and survival. Postgrad Med J 1998; 74:482-485.